Commercial vaccines provide limited protection to NADC30-like PRRSV infection
详细信息 查看全文
- 作者：Xiaofei Baib ; 1 ; Yuzhou Wangb ; 1 ; Xin Xub ; 1 ; Zhe Sunb ; Yan Xiaob ; Guobiao Jib ; Yingying Lib ; Feifei Tanb ; Xiangdong Lib ; xiaonanzhong@163.com" class="auth_mail" title="E-mail the corresponding author ; Kegong Tiana ; b ; c ; tiankg@263.net" class="auth_mail" title="E-mail the corresponding author
- 关键词：NADC30-like PRRSV ; Commercial PRRSV vaccines ; Vaccine efficacy
- 刊名：Vaccine
- 出版年：2016
- 出版时间：4 November 2016
- 年：2016
- 卷：34
- 期：46
- 页码：5540-5545
- 全文大小：2214 K
文摘
- •
Five PRRSV vaccines have been tested for the efficacy to NADC30-like PRRSV challenge.
- •
Vaccinated pigs had improved clinical manifestations compared to unvaccinated ones.
- •
However, vaccinated pigs developed similar viremia and suffered pathological lesions.
- •
PRRSV vaccines could not provide complete protection to NADC30-like PRRSV infection.